AMVUTTRA was proven to help people living with ATTR-CM and hATTR-PN

The first and only silencer for ATTR-CM and hATTR-PN

Discover how it works

People with ATTR-CM lived longer and had fewer heart-related hospital visits*

Explore this study

People with hATTR-PN had better nerve function

Explore this study

Just 4 injections a year given by a healthcare provider

Learn how to take it

*Most deaths were heart-related. Hospital visits included hospital stays and urgent visits.

Ask your doctor if AMVUTTRA is right for your journey.

Explore savings and support options

Learn more

How a former pro football player is tackling ATTR-CM with heart

Hear his story

Click to play AMVUTTRA video

Pete Shaw, living with hATTR-CM and taking AMVUTTRA. Paid spokesperson.

Envision a different journey with ATTR-CM

Watch video

Click to play AMVUTTRA video

Common questions about ATTR amyloidosis

These are answers to commonly asked questions. Talk to your doctor for more information.

ATTR‑CM is an underdiagnosed disease caused by misfolded transthyretin (TTR) proteins that build up in the heart. ATTR‑CM is commonly associated with heart (cardiac) symptoms such as abnormal heart rhythms (arrhythmias), shortness of breath, and serious health conditions including heart failure.

ATTR-CM is a disease caused by misfolded transthyretin (TTR) proteins that build up as amyloid deposits in the heart. Heart failure is a condition where the heart can’t pump blood properly. Heart failure can be caused by several factors, including coronary heart disease, high blood pressure, and ATTR‑CM. When ATTR‑CM worsens, it can lead to heart failure with symptoms like shortness of breath, fatigue, and swelling of the legs.

To diagnose ATTR-CM, your doctor may order a heart biopsy or scan to check for amyloid deposits in your heart. Your doctor might also suggest a genetic test to determine if you have wild-type or hereditary ATTR-CM, which indicates if other family members are at risk of developing the disease.

ATTR-CM is often misdiagnosed because its symptoms often overlap with other common heart conditions. In some cases, people may have both another condition and ATTR-CM, making it difficult to pinpoint that their symptoms might be due to ATTR-CM.

Wild-type ATTR often affects men who are 60 years or older, while hereditary ATTR can affect people starting at 30 years old, depending on the variant. Both types of ATTR also affect women. If you have heart symptoms, it's important to share your symptoms with your doctor and discuss any necessary tests.

Important Safety Information

What are the most important things I should know about AMVUTTRA® (vutrisiran)?

AMVUTTRA can cause low vitamin A levels

Treatment with AMVUTTRA lowers the amount of vitamin A in your blood. Your doctor will tell you to take a vitamin A supplement every day. You should not take more than the amount of vitamin A recommended by your doctor.

Low vitamin A levels can affect vision. If you have problems with your vision (e.g., night blindness) while taking AMVUTTRA, talk to your doctor. Your doctor may refer you to an eye specialist.

What are the common side effects of AMVUTTRA?

The most common side effects of AMVUTTRA were pain in the arms or legs, pain in the joints, shortness of breath, and low vitamin A levels.

These are not all the possible side effects of AMVUTTRA. Talk to your doctor about side effects that you experience. You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA). Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088.

For additional information about AMVUTTRA, please see the full Prescribing Information.

Indications

What is AMVUTTRA?

AMVUTTRA is a prescription medicine that treats the:

  • cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce heart-related death, hospital stays and urgent visits.
  • polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults.

ATTR amyloidosis
with cardiomyopathy (also known
as ATTR cardiac amyloidosis)​

hereditary ATTR
amyloidosis with polyneuropathy

transthyretin

transthyretin
amyloidosis

Kansas City Cardiomyopathy
Questionnaire

6-minute walk test

modified Neuropathy
Impairment Score +7

Quality of Life-Diabetic
Neuropathy